SCHEMBL8590804

SCHEMBL8590804

CCCCCCCCCCc1ccc(C)c(O)c1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 1/20 0.61
PTGS2 P35354 3/20 0.58
ESR1 P03372 2/20 0.58
ADRA2A P08913 2/20 0.58
ADORA3 P0DMS8 2/20 0.58
TACR2 P21452 2/20 0.58
SLC6A2 P23975 2/20 0.58
SLC6A4 P31645 2/20 0.58
SLC6A3 Q01959 2/20 0.58
KDM4E B2RXH2 1/20 0.58
ALDH1A1 P00352 1/20 0.58
LMNA P02545 1/20 0.58
SHBG P04278 1/20 0.58
TP53 P04637 1/20 0.58
CYP3A4 P08684 1/20 0.58
HSPD1 P10809 1/20 0.58
ADRB3 P13945 1/20 0.58
HTR2C P28335 1/20 0.58
HSPE1 P61604 1/20 0.58
HIF1A Q16665 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11554693 1.00 PPARA (0.61) PPARAPTGS2ESR1ADRA2AADORA3
SCHEMBL10067551 1.00 PPARA (0.61) PPARAPTGS2ESR1ADRA2AADORA3
SCHEMBL3617672 1.00 PPARA (0.61) PPARAPTGS2ESR1ADRA2AADORA3
Potassium SCHEMBL30435596 0.98 PPARA (0.59) PPARAPTGS2ESR1ADRA2AADORA3
SCHEMBL1004694 0.92 NPC1 (0.68) PPARAPTGS2ESR1ADRA2AADORA3
SCHEMBL8400508 0.92 IGF1R (0.61) PPARANPC1HPGDMAPK1HTT
SCHEMBL9243034 0.89 DRD2 (0.53) PPARAPTGS2ESR1ADRA2AADORA3
SCHEMBL4839074 0.85 KAT8 (0.61) PPARAPTGS2ESR1ADRA2AADORA3
SCHEMBL6351263 0.85 KAT8 (0.61) PPARAPTGS2ESR1ADRA2AADORA3
SCHEMBL21612711 0.85 KAT8 (0.61) PPARAPTGS2ESR1ADRA2AADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0703780-A4 USE OF NATURAL PRODUCTS AND RELATED SYNTHETIC COMPOUNDS FOR THE TREATMENT OF CARDIOVASCULAR DISEASE UNIV SYDNEY (AU) 1998-01-07 EP disclosed
CN-1124922-A Use of natural products and related synthetic compounds for the treatment of cardiovascular diseases UNIV SYDNEY (AU) 1996-06-19 CN disclosed
EP-0703780-A1 USE OF NATURAL PRODUCTS AND RELATED SYNTHETIC COMPOUNDS FOR THE TREATMENT OF CARDIOVASCULAR DISEASE THE UNIVERSITY OF SYDNEY (AU) 1996-04-03 EP disclosed